Shuttle Pharma Expands Patient Enrollment for Phase 2 Clinical Trial of Ropidoxuridine for Treatment of Patients With Glioblastoma as UVA Cancer Center Doses Its First Patient

GlobeNewswireNov 26 09:00 ET

US Manufacturing Index Rises To 43, Highest Since 2020

Business TodayNov 16 02:13 ET

Shuttle Pharmaceuticals Holdings, Inc. Advances Phase 2 Clinical Trial for Ropidoxuridine in Glioblastoma Treatment

Quiver QuantitativeNov 13 17:49 ET

Express News | Shuttle Pharmaceuticals Q3 EPS $(1.59) Down From $(0.91) YoY

BenzingaNov 13 17:10 ET

Shuttle Pharmaceuticals | 10-Q: Q3 2024 Earnings Report

SECNov 13 17:06 ET · Announcements

Express News | Shuttle Pharma Provides Third Quarter 2024 Corporate Update

ReutersNov 13 17:00 ET